obesity and glp 1

obesity and glp 1 GLP-1 Agonist to Treat Prevent Cardiovascular Disease: What Have We Achieved so Far? | Current Atherosclerosis Reports Weight Reduction with GLP-1 Agonists

Name: obesity and glp 1 GLP-1 Agonist to Treat Prevent Cardiovascular Disease: What Have We Achieved so Far? | Current Atherosclerosis Reports Weight Reduction with GLP-1 Agonists
Brand: plomberie-cannillo.fr
SKU: 37806556846
Price: 22.07 USD
Availability: InStock
Rating: 4.722700000000001 (21 reviews)

SKU: 37806556846

4.7

USD22.07 USD52.07

Pay in 4 interest-free payments of $5.52 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

Description

Glucagon-like peptide 1 protects pancreatic beta-cells from death by increasing autophagic flux and restoring lysosomal function

Novo taps Ascendis in $285m GLP-1 deal Danish pharma giant Novo Nordisk will use Ascendis TransCon platform to produce its once-monthly GLP-1 receptor agonist candidate